Based on the provided information, the S100B protein binds to the **V-domain** of the RAGE receptor. It can be used as both a **prognostic marker**, due to its correlation with disease severity and outcome, and as an **adjunct marker**, due to its lack of specificity, requiring its use in conjunction with other clinical data and biomarkers.